Thromb Haemost 1975; 34(03): 748-762
DOI: 10.1055/s-0038-1651468
Original Article
Schattauer GmbH

Adverse Effect of Heparin in Thrombin-Antithrombin III Interaction

Ewa Marciniak
1   Department of Medicine, University of Kentucky Medical Center, Lexington, Kentucky, USA.
› Author Affiliations
Further Information

Publication History

Received 09 May 1975

Accepted 20 May 1975

Publication Date:
02 July 2018 (online)

Summary

Thrombin, while reacting in the presence of heparin, impairs the inhibitory capacity of antithrombin III so that subsequent inhibition of thrombin or factor Xa is decreased or abolished. This adverse effect of heparin has been observed directly with at least 1.5 Iowa units of thrombin per each unit of purified human antithrombin III participating in the reaction. The inhibitory capacity was then totally destroyed and some residual thrombin remained in the active form. With a lower enzyme/inhibitor ratio inactivation of thrombin in the presence of heparin was fast and complete, however, a significant decrease of inhibitory capacity below that found in reaction without heparin, has been established by measuring the residual antithrombin III activity. In defibrinated human plasma at least 2 units of thrombin per each antithrombin III unit were required to demonstrate directly the adverse effect of heparin, but a fast depletion of inhibitory capacity has been also observed after repeated additions of small thrombin portions into plasma heparinized in vitro or in vivo. Portions of enzyme initially added disappeared with great velocity; subsequent portions, however, accumulated building up a high thrombin level not seen in the absence of heparin. The accumulation of residual enzyme was more extensive in plasma containing about 1 heparin unit per ml than anticoagulant at lower concentrations and was particularly noticeable in antithrombin III deficient plasma. These results may have some bearings on the approach to heparin therapy in the event when thrombin continuously generates or when a marked deficiency of antithrombin III exists.

 
  • References

  • 1 Abildgaard U. 1968; a Highly purified antithrombin III with heparin cofactor activity prepared by disc electrophoresis. Scandinavian Journal of Clinical and Laboratory Investigation 21: 89.
  • 2 Abildgaard U. 1968; b Inhibition of thrombin-fibrinogen reaction by heparin in the absence of cofactor. Scandinavian Journal of Haematology 5: 432.
  • 3 Biggs R, Denson K. W. E, Akman N, Borrett R, and Hadden M. 1970; Antithrombin III, antifactor Xa and heparin. British Journal of Haematology 19: 293.
  • 4 Briginshaw G. F, and Shanberge J. N. 1974; Identification of two distinct heparin cofactors in human plasma: II. Inhibition of thrombin and activated factor X. Thrombosis Research 4: 463.
  • 5 Brinkhous K. M, Smith H. P, Warner E. D, and Seegers W. H. 1939; The inhibition of blood clotting: an unidentified substance which acts in conjunction with heparin to prevent the conversion of prothrombin to thrombin. American Journal of Physiology 125: 683.
  • 6 Damus P. S, Hicks M, and Rosenberg R. D. 1973; Anticoagulant action of heparin. Nature 246: 355.
  • 7 Egeberg O. 1965; Inherited antithrombin deficiency causing thrombophilia. Thrombosis et Diathesis Haemorrhagica 13: 516.
  • 8 von Kaulla E, and von Kaulla K. N. 1972; Deficiency of antithrombin III activity associated with hereditary thrombosis tendency. Journal of Medicine 3: 349.
  • 9 Klein P. D, and Seegers W. H. 1950; The nature of plasma antithrombin activity. Blood 5: 742.
  • 10 Lyttleton J. W. 1954; The antithrombin activity of heparin. Biochemical Journal 8: 15.
  • 11 Marciniak E. 1970; Coagulation inhibitor elicited by thrombin. Science 170: 452.
  • 12 Marciniak E. 1973; Factor Xa inactivation by antithrombin III : evidence for biological stabilization of factor Xa by factor V-phospholipid complex. British Journal of Haematology 24: 391.
  • 13 Marciniak E. 1974; Binding of heparin in vitro and in vivo to plasma proteins. Journal of Laboratory and Clinical Medicine 84: 344.
  • 14 Marciniak E, Farley C. H, and Desimone P. A. 1974; Familial thrombosis due to antithrombin III deficiency. Blood 43: 219.
  • 15 Marciniak E, and Tsukamura S. 1972; Two progressive inhibitors of factor Xa in human blood. British Journal of Haematology 22: 341.
  • 16 Monkhouse F. C, France E. S, and Seegers W. H. 1955; Studies on the antithrombin and heparin cofactor activities of a fraction adsorbed from plasma by aluminium hydroxide. Circulation Research 3: 397.
  • 17 Rosenberg R. D, and Damus P. S. 1973; The purification and mechanism of action of human antithrombin-heparin cofactor. Journal of Biological Chemistry 248: 6490.
  • 18 Seegers W. H, Levine W. G, and Shepard R. S. 1958; Further studies on the purification of thrombin. Canadian Journal of Biochemistry and Physiology 36: 603.
  • 19 Seegers W. H, and Smith H. P. 1942; Factors which influence the activity of purified thrombin. American Journal of Physiology 137: 348.
  • 20 Seegers W. H, Warner E. D, Brinkhouse K. M, and Smith H. P. 1942; Heparin and the antithrombic activity of plasma. Science 96: 300.
  • 21 Van der Meer J, Stoepman-van Dalen E. A, and Jansen J. M. S. 1973; Antithrombin III deficiency in a Dutch family. Journal of Clinical Pathology 26: 532.
  • 22 Wessler S. 1975; Small doses of heparin and a new concept of hypercoagulability. Thrombosis et Diathesis Haemorrhagica 33: 81.
  • 23 Yin E. T, Wessler S, and Stoll P. 1971; Identity of plasma activated factor X inhibitor with antithrombin III and heparin cofactor. Journal of Biological Chemistry 246: 3712.